LIFE SCIENCE  | 
PHYSICAL SCIENCE  | 
RESEARCH TOOLS  | 
SOFTWARE AND COPYRIGHT
TECHNOLOGY COMMERCIALIZATION HOME  | 
SEARCH
Search Results - anti-cancer
11
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
A method to induce ferroptosis and to downregulate androgen receptor/androgen receptor splice variant in prostate cancer cells
Prostate cancer (PCa) effects approximately three million men in the United States every year. About 10-20% of the cases of prostate cancer are castrate-resistant prostate cancer (CRPC). This form of PCa is highly resistant to what Is known as androgen depletion therapy and is often fatal. All types of PCa are sensitive to androgen receptor signaling...
Published: 10/26/2023
|
Inventor(s):
Zhihui Qin
,
Liping Xu
Keywords(s):
Anti-cancer
,
Cancer
,
Cancer Therapies
,
Drug Delivery
,
Drug Target
,
Prostate Cancer
Category(s):
Medical
,
Diseases
,
Drug Discovery
,
Pharmaceuticals
,
Oncology
Fc-folate conjugate for the treatment of triple negative breast cancer
Approximately 13% of women in the United States will develop breast cancer according to the American Cancer Society. That makes breast cancer the second leading cause of cancer death in women right behind lung cancer. Triple negative breast cancer (TNBC) represents about 10 – 20% of all breast cancers. Triple negative refers to cancer cells...
Published: 12/7/2022
|
Inventor(s):
Cecilia Speyer
Keywords(s):
Anti-cancer
,
Breast Cancer
,
Cancer
,
Cancer Therapies
Category(s):
Antibodies
,
Assays
,
Biology
,
Biomedical
,
Chemical Processing/Synthesis
,
Diseases
,
Drug Delivery
,
Life Science
,
Oncology
,
Protein/peptides
,
Receptors/targets
,
Small molecule
,
Therapeutics
Anti-Cancer
Activity of a 2,5-Substituted Pyrimidine
This technology is a novel class of compounds that induce apoptosis in cancerous cells. BackgroundARR molecules (adamantyl-substituted retinoid-related) are a unique class of compounds which have been found to induce apoptosis, or cell death, in a large number of tumor types. SHP plays a role in cellular proliferation. Molecules that Interfere with...
Published: 12/7/2022
|
Inventor(s):
Joseph Fontana
,
Ramzi Mohammad
,
Lulu Farhana
,
Amro Aboukameel
,
Marcia Dawson
,
Zebin Xia
Keywords(s):
Analog or Analogue
,
Anti-cancer
Category(s):
Life Science
,
Oncology
,
Therapeutics
,
Diseases
SH80 Combinations
BackgroundSH35/SH80 evolved from an effort to improve upon the anti-tumor activity of XK469. XK469 is a compound, currently in Phase 1 clinical trials. The clinical trials include patients with bladder, breast, colorectal, esophageal, head and neck, kidney, liver, lung, mesothelioma, pancreas and sarcoma cancers. Moving a chlorine atom from one position...
Published: 3/2/2022
|
Inventor(s):
Lisa Polin
Keywords(s):
Anti-cancer
,
Compound
Category(s):
Life Science
,
Oncology
,
Therapeutics
Activated T Cells and Activated T Cells Armed with BiSpecific Antibodies Directed at Cancer Antigens are Poor Responders to Alloantigens May Help Engraftment and Improve Anti-Tumor Effects
BackgroundThe treatment of hematologic malignancies with allogeneic stem cell transplant is limited by the numbers of allogeneic donors. Umbilical cord blood stem transplants have been an important alternative source of hematopoietic stem cells. However, failure or delayed engraftment remains the critical barrier to the success of the transplants....
Published: 3/2/2022
|
Inventor(s):
Lawrence Lum
Keywords(s):
Anti-cancer
Category(s):
Life Science
,
Therapeutics
,
Diseases
,
Infectious disease
Para-Amino Substituent on the D Ring of Green Tea Polyphenol Epigallocatechin-3-Gallate as Novel Proteasome Inhibitor and Cancer Apoptosis Inducer
This technology is a group of (-)EGCG analogs with stable and improved anti-tumor activities. Background & Unmet Need:Catechins are a type of plant-derived antioxidant whose biological activities may play an effect on cancer prevention. Green tea has long been lauded to have ingredients that protect cells from the DNA damage that causes cancer....
Published: 2/28/2022
|
Inventor(s):
Qingping Dou
,
Kristin Landis-Piwowar
,
Tak-Hang Chan
,
Kumi Osanai
Keywords(s):
Anti-cancer
,
Breast Cancer
,
Compound
,
Prostate Cancer
Category(s):
Life Science
,
Oncology
,
Therapeutics
,
Diseases
Translation Regulated (TR)-Mediated Gene Expression: Novel Expression and Reporter Vectors
Background: Often referred to as the crucial "drug discovery tool", cell based technology is one of the most significant sectors of pharmaceutical research and development. Of particular importance has been the development of information-rich cellular assays that determine drug candidate efficacy and safety (target identification, validation...
Published: 4/17/2022
|
Inventor(s):
Leon Carlock
,
Maria Cypher
Keywords(s):
Animal Model
,
Anti-cancer
,
Cancer
,
Cancer risk
,
Cancer Therapies
,
Diagnostics
,
Imaging
,
Therapeutics
Category(s):
Life Science
,
Diagnostics
,
Research tools
,
Assays
,
Cell lines
,
Oncology
GlyB4 Fusion with Neuregulin Heparin-Targeting Domain to Block Neuregulin Signaling
We have harnessed this natural targeting ability of NRG by fusing the HBD of NRG to soluble HER4. This fusion protein retains high affinity heparin binding to heparin and to cells that express heparan sulfates resulting in a more potent NRG antagonist. In vivo, it is targeted to peripheral nerve segments where it blocks the activity of NRG as a Schwann...
Published: 12/6/2022
|
Inventor(s):
Jeffrey Loeb
,
Qunfang Lee
Keywords(s):
Anti-cancer
,
Biotechnology
,
Cancer risk
,
Cancer Therapies
,
Drug Delivery
,
Drug Target
,
Epilepsy
Category(s):
Life Science
,
Drug Delivery
,
Other
Repurposing AKT Inhibitors for the Treatment of Protein Misfolding and Protein Trafficking Diseases
WSU researchers have generated a reagent to understand the degenerative processes occurring in Pelizaeus‑Merzbacher disease (PMD) and to study the intracellular signaling that occurs because of these diseased processes. They have deduced that the use of AKT inhibitors may reduce disease severity in patients with a wide range of degenerative diseases. Background...
Published: 2/8/2022
|
Inventor(s):
Alexander Gow
,
Cherie Southwood
Keywords(s):
Alzheimer's Disease
,
Anti-cancer
,
Neuro-disorders
,
Parkinson's
Category(s):
Life Science
,
Neurological disorders
,
Therapeutics
,
Diseases
Hox B4
This invention is a novel therapy for cancer using Hox B4 to induce apoptosis in leukemia cell lines. Background & Unmet Need: B‑cell chronic lymphocytic leukemia is the most common type of leukemia in adults. The B cells grow uncontrollably and invade the bone marrow and blood where they crowd out the healthy cells. There is a need to...
Published: 10/5/2018
|
Inventor(s):
Kamal Mubarak
,
Ramzi Mohammad
,
Robert Pauley
,
Larry Tait
Keywords(s):
Anti-cancer
,
Gene
,
Protein
Category(s):
Therapeutics
,
Life Science
,
Oncology
,
Diseases
1
2